Search results
Showing 8101 to 8115 of 8973 results
Discontinued Reference number: GID-TA11179
Discontinued Reference number: GID-TA11180
Exploratory work regarding the use of bevacizumab in the treatment of eye conditions [ID422]
Discontinued Reference number: GID-TA11205
Discontinued Reference number: GID-TA11207
Ovarian (epithelial), fallopian, peritoneal cancer - paclitaxel (encapsulated in XR-17 [ID565]
Discontinued Reference number: GID-TA11209
Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]
Discontinued Reference number: GID-HST10004
Discontinued Reference number: GID-MT130
In development Reference number: GID-TA10589 Expected publication date: TBC
Atezolizumab for adjuvant treatment of renal cell carcinoma with a high risk of metastasis [ID5101]
Discontinued Reference number: GID-TA11000
In development Reference number: GID-TA11104 Expected publication date: TBC
Discontinued Reference number: GID-TA10996
Discontinued Reference number: GID-TA10965
Parsaclisib for treating relapsed or refractory marginal zone lymphoma [ID3976]
Discontinued Reference number: GID-TA10863
Discontinued Reference number: GID-TA10766
Filgotinib for treating moderately to severely active Crohn's disease [ID6236]
Discontinued Reference number: GID-TA11244